Literature DB >> 25738283

Association of genetic polymorphisms in the telomerase reverse transcriptase gene with prostate cancer aggressiveness.

Dapeng Wu1, Hongjie Yu2, Jielin Sun3, Jun Qi1, Qiang Liu1, Ruipeng Li1, Siqun Lily Zheng3, Jianfeng Xu2, Jian Kang1.   

Abstract

Telomerase reverse transcriptase (TERT), encoded by the TERT gene, is an essential component of telomerase, essential for the maintenance of telomere DNA length, chromosomal stability and cellular immortality. The aim of the present study was to evaluate the association between common genetic variations across the TERT gene region and prostate cancer (PCa) aggressiveness in a Chinese population. A total of 12 TERT tagging single-nucleotide polymorphisms (SNPs) were genotyped on the Sequenom Mass-ARRAY iPLEX® platform in a case-case study with 1,210 Chinese patients with PCa. Unconditional logistic regression was used to investigate the association of genotypes with PCa aggressiveness, Gleason grade and risk of developing early-onset PCa. It was observed that the C allele of the TERT intron 2 SNP (rs2736100) was significantly associated with reduced risk of PCa aggressiveness [odds ratio (OR)=0.81; 95% confidence interval (CI): 0.66-0.99; P=0.037]. This allele was also significantly correlated with a reduced risk of developing a tumor with a high Gleason score (>7; OR=0.83; 95% CI: 0.70-0.99; P=0.039). The T allele of the intron 4 SNP (rs10069690) was found to be significantly associated with a decreased risk for an aggressive form of PCa (OR=0.76; 95% CI: 0.59-0.97; P=0.030). In addition, the A allele of rs10078761 located at the 3' end of the TERT gene exhibited a statistically significant association with the reduced risk of developing a higher grade disease (OR=0.48; 95% CI: 0.28-0.81; P=0.006). However, no association between TERT polymorphisms and age at diagnosis was observed in the present study. The present findings demonstrated for the first time, to the best of our knowledge, that genetic variations across the TERT gene are associated with PCa aggressiveness in a Chinese Han population.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25738283     DOI: 10.3892/mmr.2015.3410

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  7 in total

1.  Association between TERT rs2853669 polymorphism and cancer risk: A meta-analysis of 9,157 cases and 11,073 controls.

Authors:  Zhengsheng Liu; Tao Wang; Zhun Wu; Kaiyan Zhang; Wei Li; Jianbin Yang; Chenxi Chen; Lei Chen; Jinchun Xing
Journal:  PLoS One       Date:  2018-03-13       Impact factor: 3.240

2.  Genetic variants in TERT are associated with risk of gastric cancer in a Chinese Han population.

Authors:  Xianglong Duan; Wei Cao; Lijie Wang; Sida Liu; Zhao Liu; Bolun Zhang; Hua Yang; Tian Feng; Jiayi Zhang; Xiyang Zhang; Yanbin Long; Tianbo Jin
Journal:  Oncotarget       Date:  2016-12-13

3.  Association of TERT polymorphisms with chronic hepatitis B in a Chinese Han population.

Authors:  Guoxia Ren; Xu Liu; Zhendong Yu; Jingjie Li; Fanglin Niu; Tianbo Jin; Jikui Liu; Mingwei Chen
Journal:  Oncotarget       Date:  2018-01-03

4.  Association of TERT gene polymorphisms with clinical benign prostatic hyperplasia in a Chinese Han population of the Northwest region.

Authors:  Guangrui Fan; Kun Li; Yangyang Pang; Youli Zhao; Yan Tao; Huimin Gui; Hanzhang Wang; Robert Svatek; Ronald Rodriguez; Zhiping Wang
Journal:  Transl Androl Urol       Date:  2021-02

Review 5.  Telomere Maintenance Mechanisms in Cancer.

Authors:  Tiago Bordeira Gaspar; Ana Sá; José Manuel Lopes; Manuel Sobrinho-Simões; Paula Soares; João Vinagre
Journal:  Genes (Basel)       Date:  2018-05-03       Impact factor: 4.096

6.  Genetic variations in TERC and TERT genes are associated with renal cell carcinoma risk in a Chinese Han population.

Authors:  Dapeng Wu; Guodong Zhu; Jin Zeng; Wenbin Song; Ke Wang; Xinyang Wang; Peng Guo; Dalin He
Journal:  Oncotarget       Date:  2017-08-10

7.  Association of TERT, OGG1, and CHRNA5 Polymorphisms and the Predisposition to Lung Cancer in Eastern Algeria.

Authors:  Asma Mimouni; Etienne Rouleau; Patrick Saulnier; Amina Marouani; Med Lamine Abdelali; Taha Filali; Leila Beddar; Abdelhak Lakehal; Ahmed Hireche; Asma Boudersa; Mahmoud Aissaoui; Hacene Ramtani; Khalid Bouhedjar; Djamel Abdellouche; Messaouda Oudjehih; Ibtissem Boudokhane; Noureddine Abadi; Dalila Satta
Journal:  Pulm Med       Date:  2020-03-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.